I'm currently the primary point of contact for assigned clinical trial sites at ICON (KCR CRO), overseeing monitoring, compliance, issue resolution, and study progress. Across 8+ years in CRO, sponsor, and site environments, I've supported Phase I–IV pharmaceutical, biotechnology, and medical device studies.
I've conducted 80+ Site Initiation Visits, 250+ Interim Monitoring Visits, and 70+ Closeout Visits. My work spans site management, risk-based monitoring, SDV/SDR, TMF oversight, investigational product accountability, subject safety, protocol compliance, CAPA management, and inspection readiness.
I've supported studies at Johnson & Johnson, TFS HealthScience, IQVIA, PPD, Syneos Health, CooperVision, Stryker Neurovascular, and Stanford Hospital & Clinics. I work across oncology, infectious disease, neurology, CNS, cardiology, nephrology, diabetes, ophthalmology, and pain management using clinical systems including Medidata Rave, Veeva, Suvoda, and Siebel.
